|
1
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dadashzadeh K, Peppelenbosch MP and Adamu
AI: Helicobacter pylori pathogenicity factors related to
gastric cancer. Can J Gastroenterol Hepatol. 2017:79424892017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buckland G, Travier N, Huerta JM,
Bueno-de-Mesquita HB, Siersema PD, Skeie G, Weiderpass E, Engeset
D, Ericson U, Ohlsson B, et al: Healthy lifestyle index and risk of
gastric adenocarcinoma in the EPIC cohort study. Int J Cancer.
137:598–606. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Laszewicz W, Iwanczak F and Iwanczak B;
Task Force of the Polish Society of Gastroenterology, : Task Force
of the Polish Society of Gastroenterology: Seroprevalence of
Helicobacter pylori infection in Polish children and adults
depending on socioeconomic status and living conditions. Adv Med
Sci. 59:147–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ko KP, Shin A, Cho S, Park SK and Yoo KY:
Environmental contributions to gastrointestinal and liver cancer in
the Asia-Pacific region. J Gastroenterol Hepatol. 33:111–120. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zylberberg HM, Sultan K and Rubin S:
Hereditary diffuse gastric cancer: One family's story. World J Clin
Cases. 6:1–5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamashita S, Kishino T, Takahashi T,
Shimazu T, Charvat H, Kakugawa Y, Nakajima T, Lee YC, Iida N, Maeda
M, et al: Genetic and epigenetic alterations in normal tissues have
differential impacts on cancer risk among tissues. Proc Natl Acad
Sci USA. 115:1328–1333. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen B, Wang J, Gu X, Zhang J and Feng X:
The DNMT3B −579G>T polymorphism is significantly associated with
the risk of gastric cancer but not lung cancer in chinese
population. Technol Cancer Res Treat. 16:1259–1265. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ajani JA: Evolving chemotherapy for
advanced gastric cancer. Oncologist. 3 (Suppl 10):S49–S58. 2005.
View Article : Google Scholar
|
|
11
|
Menges M and Hoehler T: Current strategies
in systemic treatment of gastric cancer and cancer of the
gastroesophageal junction. J Cancer Res Clin Oncol. 135:29–38.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tripathi PP, Arami H, Banga I, Gupta J and
Gandhi S: Cell penetrating peptides in preclinical and clinical
cancer diagnosis and therapy. Oncotarget. 9:37252–37267. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mullick Chowdhury S, Lee T and Willmann
JK: Ultrasound-guided drug delivery in cancer. Ultrasonography.
36:171–184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li P, Zheng Y, Ran H, Tan J, Lin Y, Zhang
Q, Ren J and Wang Z: Ultrasound triggered drug release from
10-hydroxycamptothecin-loaded phospholipid microbubbles for
targeted tumor therapy in mice. J Control Release. 162:349–354.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Negishi Y, Endo-Takahashi Y and Maruyama
K: Gene delivery systems by the combination of lipid bubbles and
ultrasound. Drug Discov Ther. 10:248–255. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Elnaggar MA, Subbiah R, Han DK and Joung
YK: Lipid-based carriers for controlled delivery of nitric oxide.
Expert Opin Drug Deliv. 14:1341–1353. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Delalande A, Kotopoulis S, Postema M,
Midoux P and Pichon C: Sonoporation: Mechanistic insights and
ongoing challenges for gene transfer. Gene. 525:191–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hynynen K, McDannold N, Sheikov NA, Jolesz
FA and Vykhodtseva N: Local and reversible blood-brain barrier
disruption by noninvasive focused ultrasound at frequencies
suitable for trans-skull sonications. Neuroimage. 24:12–20. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mayer CR, Geis NA, Katus HA and
Bekeredjian R: Ultrasound targeted microbubble destruction for drug
and gene delivery. Expert Opin Drug Deliv. 5:1121–1138. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen WS, Matula TJ and Crum LA: The
disappearance of ultrasound contrast bubbles: Observations of
bubble dissolution and cavitation nucleation. Ultrasound Med Biol.
28:793–803. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu W, Cheng Y, Guo BH and Wu Q:
Pharmacokinetics of liver-targeted docetaxel liposomes modified
with 6-O-acyl-D-galactose esters in rabbits. Biomed Rep. 2:545–548.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deng CX, Sieling F, Pan H and Cui J:
Ultrasound-induced cell membrane porosity. Ultrasound Med Biol.
30:519–526. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou Y, Kumon RE, Cui J and Deng CX: The
size of sonoporation pores on the cell membrane. Ultrasound Med
Biol. 35:1756–1760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mehier-Humbert S, Bettinger T, Yan F and
Guy RH: Plasma membrane poration induced by ultrasound exposure:
Implication for drug delivery. J Control Release. 104:213–222.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Uemura N, Kikuchi S, Sato Y, Ohnuma H,
Okamoto K, Miyamoto H, Hirakawa M, Sagawa T, Fujikawa K, Takahashi
Y, et al: A phase II study of modified docetaxel, cisplatin, and
S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer.
Cancer Chemother Pharmacol. 80:707–713. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mitsui Y, Sato Y, Miyamoto H, Fujino Y,
Takaoka T, Miyoshi J, Kagawa M, Ohnuma H, Hirakawa M, Kubo T, et
al: Trastuzumab in combination with docetaxel/cisplatin/S-1 (DCS)
for patients with HER2-positive metastatic gastric cancer:
Feasibility and preliminary efficacy. Cancer Chemother Pharmacol.
76:375–382. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim HS, Ryu MH, Zang DY, Ryoo BY, Yang DH,
Cho JW, Lim MS, Kim MJ, Han B, Choi DR, et al: Phase II study of
docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic
gastric cancer. Gastric Cancer. 19:579–585. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Chang R, Li M, Zhao K, Zheng H
and Zhou X: Docetaxel-loaded lipid microbubbles combined with
ultrasound-triggered microbubble destruction for targeted tumor
therapy in MHCC-H cells. Onco Targets Ther. 9:4763–4771. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chazotte B: Labeling mitochondria with
JC-1. Cold Spring Harb Protoc 2011. pii:pdb.prot065490. 2011.
|
|
30
|
Tangutur AD, Kumar D, Krishna KV and
Kantevari S: Microtubule targeting agents as cancer
chemotherapeutics: An overview of molecular hybrids as stabilizing
and destabilizing agents. Curr Top Med Chem. 17:2523–2537. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Farha NG and Kasi A: Docetaxel. StatPearls
[Internet]. StatPearls Publishing; Treasure Island, FL: 2019
|
|
32
|
Lyseng-Williamson KA and Fenton C:
Docetaxel: A review of its use in metastatic breast cancer. Drugs.
65:2513–2531. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Haag P, Frauscher F, Gradl J, Seitz A,
Schäfer G, Lindner JR, Klibanov AL, Bartsch G, Klocker H and Eder
IE: Microbubble-enhanced ultrasound to deliver an antisense
oligodeoxynucleotide targeting the human androgen receptor into
prostate tumours. J Steroid Biochem Mol Biol. 102:103–113. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xing W, Gang WZ, Yong Z, Yi ZY, Shan XC
and Tao RH: Treatment of xenografted ovarian carcinoma using
paclitaxel-loaded ultrasound microbubbles. Acad Radiol.
15:1574–1579. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kang J, Wu X, Wang Z, Ran H, Xu C, Wu J,
Wang Z and Zhang Y: Antitumor effect of docetaxel-loaded lipid
microbubbles combined with ultrasound-targeted microbubble
activation on VX2 rabbit liver tumors. J Ultrasound Med. 29:61–70.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grainger SJ, Serna JV, Sunny S, Zhou Y,
Deng CX and El-Sayed ME: Pulsed ultrasound enhances nanoparticle
penetration into breast cancer spheroids. Mol Pharm. 7:2006–2019.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shi F, Yang F, He X, Zhang Y, Wu S, Li M,
Zhang Y, Di W, Dou J and Gu N: Inhibitory effect of
epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2
antibody combined with therapeutic ultrasound on multiple myeloma
cancer stem cells. J Drug Target. 24:34–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ren ST, Shen S, He XY, Liao YR, Sun PF,
Wang B, Zhao WB, Han SP, Wang YL and Tian T: The effect of
docetaxel-loaded micro-bubbles combined with low-frequency
ultrasound in H22 hepatocellular carcinoma-bearing mice. Ultrasound
Med Biol. 42:549–560. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang Y, Bai W, Chen Y, Nan S, Lin Y, Ying
T and Hu B: Low-frequency ultrasound-mediated microvessel
disruption combined with docetaxel to treat prostate carcinoma
xenografts in nude mice: A novel type of chemoembolization. Oncol
Lett. 12:1011–1018. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim JH, Yoon EK, Chung HJ, Park SY, Hong
KM, Lee CH, Lee YS, Choi K, Yang Y, Kim K and Kim IH: p53
acetylation enhances Taxol-induced apoptosis in human cancer cells.
Apoptosis. 18:110–120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guo J, Yang Y, Linghu E, Zhan Q, Brock MV,
Herman JG, Zhang B and Guo M: RASSF10 suppresses colorectal cancer
growth by activating P53 signaling and sensitizes colorectal cancer
cell to docetaxel. Oncotarget. 6:4202–4213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Singh SK, Banerjee S, Acosta EP, Lillard
JW and Singh R: Resveratrol induces cell cycle arrest and apoptosis
with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and
p27KIP1 pathway. Oncotarget. 8:17216–17228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pirollo KF, Nemunaitis J, Leung PK, Nunan
R, Adams J and Chang EH: Safety and efficacy in advanced solid
tumors of a targeted nanocomplex carrying the p53 gene used in
combination with docetaxel: A phase 1B study. Mol Ther.
24:1697–1706. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhao L, Feng Y, Shi A, Zong Y and Wan M:
Apoptosis induced by microbubble-assisted acoustic cavitation in
K562 cells: The predominant role of the cyclosporin a-dependent
mitochondrial permeability transition pore. Ultrasound Med Biol.
41:2755–2764. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang SL, Tang KQ, Bai WK, Zhao YW, Shen E,
Tao JJ and Hu B: Combined low-frequency ultrasound and microbubble
contrast agent for the treatment of benign prostatic hyperplasia. J
Endourol. 27:1020–1026. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Maes ME, Schlamp CL and Nickells RW: BAX
to basics: How the BCL2 gene family controls the death of retinal
ganglion cells. Prog Retin Eye Res. 57:1–25. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kordezangeneh M, Irani S, Mirfakhraie R,
Esfandyari-Manesh M, Atyabi F and Dinarvand R: Regulation of
BAX/BCL2 gene expression in breast cancer cells by docetaxel-loaded
human serum albumin nanoparticles. Med Oncol. 32:2082015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Haldar S, Basu A and Croce CM: Bcl2 is the
guardian of microtubule integrity. Cancer Res. 57:229–233.
1997.PubMed/NCBI
|
